Hot on the heels of the first generic Ozempics (semaglutide for type 2 diabetes), the first generic Wegovy (semaglutide for weight management), called Sevmia, has now been approved by Health Canada. The Sevmia product monograph provides dosing guidance to reach ‘the therapeutic and maintenance dose’ of 2.4mg weekly, which mirrors the approval and maximum dose […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.